Skip to main content

Table 1 Patient characteristics by chemotherapy regimen received

From: Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients

Patient Characteristics

Regimen of chemotherapy

P-value

 

FEC (n = 78)

TE (n = 66)

NE (n = 26)

 

Age at diagnosis, y

Mean

42.72

41.62

43.96

0.20

SD

5.01

6.42

6.57

 

Pathology

IDC

70

59

23

1.00

Other

8

7

3

 

Stage at diagnosis

I

30 (38.46%)

 

4 (15.38%)

< 0.001

II

48 (61.54%)

36 (54.55%)

15 (57.69%)

 

III

 

30 (45.45%)

7 (26.92%)

 

Tamoxifen use, n (%)

Yes

55 (70.51%)

44 (66.67%)

19 (73.08%)

0.832

No

23 (29.49%)

22 (33.33%)

7 (26.92%)

 
  1. SD standard deviation; IDC infitrating ductal carcinoma